Gabelli Funds’ Chris Marangi on Rollins, Republic Services and American Express
Can Skydance Break the Media M&A Curse?
Galleri Panel Aftermath: What Investors And Rivals See Next For MCEDs As FDA Decision Looms
Grail’s cancer blood test on the brink of receiving groundbreaking FDA approval
Revenue at OpenAI and Anthropic will continue to be very important, says Gabelli Funds’ John Belton
Earnings season kicks into high gear as big banks report next week. Here’s what’s ahead
Sports gambling seeps even deeper into Wall Street’s world as hundreds of pro team ETFs emerge
A true ‘nuclear renaissance’ is taking shape, and these stocks could be big winners
Option Care Health Shares Soar as Infusion Therapy Firm Agrees to Be Acquired for $5.8B
Vance’s fraud crackdown may raise costs for US health insurers, enrollees
Gabelli Funds’ Tony Bancroft on his top defense stock picks
Prizes and ‘mega risks’ of a Uniper deal for RWE and Equinor
